{"DataElement":{"publicId":"6543091","version":"1","preferredName":"iRECIST Assessment Discontinuation Other Specify","preferredDefinition":"A reason other than those previously specified to describe why the collection of iRECIST results was permanently stopped..","longName":"IRECIST_ASMT_END_SPEC","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6543085","version":"1","preferredName":"iRECIST Assessment Discontinuation","preferredDefinition":"A modification of the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, for use as a standard approach to solid tumor measurements and definitions for objective change in tumor size in cancer clinical trials in which an immunotherapy is used._The final result of a determination of the value, significance, or extent of._To stop or end, permanently or temporarily.","longName":"6543082v1.0:6543083v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6543082","version":"1","preferredName":"Immune-Modified Response Evaluation Criteria in Solid Tumors","preferredDefinition":"A modification of the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, for use as a standard approach to solid tumor measurements and definitions for objective change in tumor size in cancer clinical trials in which an immunotherapy is used.","longName":"C136711","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Modified Response Evaluation Criteria in Solid Tumors","conceptCode":"C136711","definition":"A modification of the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, for use as a standard approach to solid tumor measurements and definitions for objective change in tumor size in cancer clinical trials in which an immunotherapy is used.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"791133C3-F612-5CA6-E053-F662850AB671","latestVersionIndicator":"Yes","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"ONEDATA","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6543083","version":"1","preferredName":"Assessment Discontinue","preferredDefinition":"The final result of a determination of the value, significance, or extent of.:To stop or end, permanently or temporarily.","longName":"C25217:C25484","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"791133C3-F623-5CA6-E053-F662850AB671","latestVersionIndicator":"Yes","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"ONEDATA","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"iRECIST:  Immune Response Evaluation Criteria in Solid Tumours (RECIST)-2017","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"791133C3-F634-5CA6-E053-F662850AB671","latestVersionIndicator":"Yes","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"KNABLEJ","dateModified":"2018-10-25","changeDescription":"10/28/18 jk created for EORTC AISBL-IVZW form and RECIST FG content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2666713","version":"2","preferredName":"Other Specify","preferredDefinition":"Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.","longName":"OTH_SPEC","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208051","version":"1","preferredName":"Other Specify","preferredDefinition":"Not otherwise specified.:Specify; be specific about something; define clearly.","longName":"C17649:C25685","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3B5E-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"132D4785-528E-5337-E050-BB89AD433CA8","latestVersionIndicator":"Yes","beginDate":"2015-04-07","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"HARTLEYG","dateModified":"2018-06-06","changeDescription":"7/19/17 jk transferred context and added registration status, CSI per Round 5 finalization task. 4/28/15 released. jc  4/7/15 VD versioned per COG WG: inc to 100 char, remove min limit, chg concept domain to assessment result. jc 1/25/13 added ACRIN Old caBIG CSI.  3/21/12 - changed origin from IVI to ACRIN.  3/5/08 - released for UoWASH FES CRF.   7/23/07-created for ACRIN PET CDEs","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635324","version":"1","longName":"RECIST","context":"NCI Standards"},{"publicId":"6006601","version":"1","longName":"iRECIST","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Specify reason","type":"Preferred Question Text","description":"Specify reason","url":null,"context":"NCI Standards"}],"origin":"iRECIST:  Immune Response Evaluation Criteria in Solid Tumours (RECIST)-2017","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"790E84EF-09F3-472A-E053-F662850AE0D0","latestVersionIndicator":"Yes","beginDate":"2018-10-25","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-10-25","modifiedBy":"KNABLEJ","dateModified":"2018-10-25","changeDescription":"10/25/18 jk created for EORTC AISBL-IVZW iRECIST follow up form and iRECIST FG content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}